PridCor Therapeutics, LLC

CIK 2074593 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for PridCor Therapeutics, LLC.

Recent SEC filings

FiledFormAccession number
Jul 6, 2026D/A0002074593-26-000003
May 8, 2026D0002074593-26-000002
Feb 2, 2026D0002074593-26-000001
Jun 25, 2025D0002074593-25-000001